支架内再狭窄患者第一代或第二代药物洗脱支架植入术后两年的转归。一项PRODIGY试验的子研究。 - Suppr

Suppr

超能文献

Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy.

作者信息

Campo Gianluca, Punzetti Silvia, Malagù Michele, Ferrari Roberto, Valgimigli Marco

机构信息

Cardiovascular Institute, Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy; LTTA Center, Ferrara, Italy.

Cardiovascular Institute, Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy.

出版信息

Int J Cardiol. 2014 May 1;173(2):343-5. doi: 10.1016/j.ijcard.2014.03.028. Epub 2014 Mar 15.

DOI:10.1016/j.ijcard.2014.03.028

PMID:24680246

Abstract

摘要

相似文献

Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy.支架内再狭窄患者第一代或第二代药物洗脱支架植入术后两年的转归。一项PRODIGY试验的子研究。

Int J Cardiol. 2014 May 1;173(2):343-5. doi: 10.1016/j.ijcard.2014.03.028. Epub 2014 Mar 15.

Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.随机比较依维莫司洗脱支架与西罗莫司洗脱支架治疗糖尿病患者新发冠状动脉疾病（ESSENCE-DIABETES）：来自 ESSENCE-DIABETES 试验的结果。

Circulation. 2011 Aug 23;124(8):886-92. doi: 10.1161/CIRCULATIONAHA.110.015453. Epub 2011 Aug 1.

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).全患者人群行经皮冠状动脉介入治疗后第一代或第二代药物洗脱支架或裸金属支架植入术后 2 年的结果：来自 PRODIGY 研究（支架内内膜增生分级后延长双联抗血小板治疗研究）的预先指定分析。

JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.

Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.用于治疗药物洗脱支架再狭窄的紫杉醇涂层球囊：情人节 I 试验的亚组分析结果

Cardiovasc Revasc Med. 2014 Jan;15(1):23-8. doi: 10.1016/j.carrev.2013.08.011.

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).经皮冠状动脉介入治疗患者中依维莫司洗脱支架与西罗莫司洗脱支架的随机比较：斯堪的纳维亚随机临床试验组织具有临床转归的 IV 期研究（SORT OUT IV）。

Circulation. 2012 Mar 13;125(10):1246-55. doi: 10.1161/CIRCULATIONAHA.111.063644. Epub 2012 Feb 3.

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.SYNTAX 评分对依维莫司和佐他莫司洗脱支架血运重建后 1 年结局的预后价值：RESOLUTE 所有患者试验的一项亚组研究。

JACC Cardiovasc Interv. 2011 Apr;4(4):432-41. doi: 10.1016/j.jcin.2011.01.008.

Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.药物洗脱支架再狭窄治疗后未保护的左主干远端的临床和操作预测因素：米兰和新东京（MITO）登记处。

Circ Cardiovasc Interv. 2012 Aug 1;5(4):491-8. doi: 10.1161/CIRCINTERVENTIONS.111.964874. Epub 2012 Jul 31.

One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohort.在一个未经过筛选的队列中，使用紫杉醇洗脱支架治疗裸金属支架内再狭窄后的一年临床结局。

Int J Cardiol. 2010 Dec 3;145(3):608-9. doi: 10.1016/j.ijcard.2010.08.062. Epub 2010 Sep 17.

Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era.小冠状动脉血管的经皮冠状动脉介入治疗：从球囊血管成形术到药物洗脱支架时代。

Indian Heart J. 2011 May-Jun;63(3):228-33.

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).在冠状动脉疾病中，依维莫司洗脱支架与紫杉醇洗脱支架的荟萃分析：SPIRIT 临床试验计划的最终 3 年结果（在治疗新发病变的患者中，使用依维莫司洗脱冠状动脉支架系统治疗的西里斯 V 依维莫司洗脱冠状动脉支架系统的临床评估）。

JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005.

引用本文的文献

Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Restenosis, and Antithrombotic Strategies.定义复杂冠状动脉病变的关键特征：基于证据的临床实践综述。第二部分：慢性完全闭塞病变、移植血管介入治疗、支架内再狭窄及抗栓策略。

Rev Cardiovasc Med. 2022 Jun 8;23(6):209. doi: 10.31083/j.rcm2306209. eCollection 2022 Jun.

Antiplatelet agents for chronic kidney disease.抗血小板药物在慢性肾脏病中的应用。

Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4.

Associations of anthropometric adiposity indexes with hypertension risk: A systematic review and meta-analysis including PURE-China.人体测量肥胖指数与高血压风险的关联：一项包括中国PURE研究的系统评价和荟萃分析

Medicine (Baltimore). 2018 Nov;97(48):e13262. doi: 10.1097/MD.0000000000013262.

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials.新一代药物洗脱支架与药物涂层球囊治疗支架内再狭窄的比较：一项随机对照试验的荟萃分析。

BMJ Open. 2018 Feb 22;8(2):e017231. doi: 10.1136/bmjopen-2017-017231.

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.海豹翼紫杉醇洗脱球囊导管治疗裸金属支架再狭窄的疗效

BMC Cardiovasc Disord. 2017 Jun 26;17(1):168. doi: 10.1186/s12872-017-0602-6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验